Utilization Rates / Implementation Rates of the Hepatitis B and C screening within the "Check-Up35+" in the German primary care setting after initiatives by the Federal Joint Committee (G-BA)

Utilization Rates / Implementation Rates of the Hepatitis B and C screening within the "Check-Up35+" in the German primary care setting after initiatives by the Federal Joint Committee (G-BA) - Utilization Rates of the Hepatitis B and C screening within the "Check-Up35+"

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029166

Enrollment

150000

Registered

2022-05-27

Start date

2021-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B18.2 B18.11

Interventions

Group 1: Noninterventional Observation Trial Retrospective and prospective non-interventional database analysis with data from 11 LADR ambulatory healthcare centres. Patients with documented Check-Up

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All “Check-up 35+” patients will be included in the analysis in the database from 01 Oct 2021 – 30 Sep 2022. Hepatitis B (HBsAg) and C (anti-HCV) screenings within the “Check-Up 35+” are identified by the code GOP 01865. The codes GOP 01866 and 01867 are used for the analysis of HBV-DNA and HCV-RNA (PCR) in case of positive HBsAg and anti-HCV screening results, respectively.

Exclusion criteria

Exclusion criteria: No specific exclusion criteria

Design outcomes

Secondary

Measure	Time frame
- Proportion of positive HBV-DNA and HCV-RNA results - Above results stratified according to age, sex, and geographical region - Proportion of unjustified screening requests (i.e. double-requests). - These proportions will be compared between the time periods before the COVID-19 pandemic and after the G-BA took effect.	—

Primary

Measure	Time frame
Proportion of HBsAg and anti-HCV screenings ordered within the study period compared to the total number of Check-Up lab requests.	—

Countries

Germany

Contacts

Public ContactJohannes Wiegand

Universitätsklinikum LeipzigKlinik für Gastroenterologie

johannes.wiegand@medizin.uni-leipzig.de+493419712330

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026